US drug approvals
1 approvals with a product on the US market
- Benznidazole NDA209570 · approved 29 Aug 2017
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Free public records show Chemo Research SL in 1 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
1 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Chemo Research SL: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Chemo Research SL is in.
Stories on the topics Chemo Research SL works in.
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Every vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches…
Read
The first CAR-T cell therapy was approved in the US in August 2017. These living drugs can work when other…
Read